In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/never-too-late-if-you-missed-ipkat-last_6.html Here is the latest recap of the posts written by the Kats since the last Never Too Late post. Image by Pixabay Copyright Nedim reported the words of Katfriends Adrian Aronsson-Storrier and Oliver Faihurst, from Lewis Silkin, on the litigation commenced by Getty against the developers of the AI image... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/uk-government-axes-plans-to-broaden.html Ready to mine … As it was explained in the Impact Assessment accompanying the Commission’s Proposal for what would eventually become and be adopted by the Parliament and the Council as the DSM Directive [Katposts here], text and data mining (TDM) is a term commonly used to describe the... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/digital-art-protectable-under-copyright.html As the well-known Sanremo Music Festival is approaching with the 2023 edition, the Italian Supreme Court recently issued decision No. 1107/2023 involving RAI – Radiotelevisione Italiana. This decision was rendered in the context of proceedings concerning the alleged unlawful use of an art work created using software in a... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/friday-fantasies.html A Kat trying to submit a paper A new month has begun and, together with that, here are the latest opportunities and events to find out about. Events 24 February 2023: “What Does My Claim Cover?” UNION-IP will hold an event, titled “What Does My Claim Cover? – Intended... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/guest-post-under-influence-influencer.html The IPKat has received and is pleased to publish another guest contribution by Danish Katfriends Jakob Plesner Mathiasen, Hanne Kirk and Thit Nymand Nisbeth (all Gorrissen Federspiel) tackling influencer marketing from an IP perspective. Here’s what they write: Under the influence: Influencer marketing – when private individuals become professionals... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/guest-post-litigation-commenced-against.html Katfriends Adrian Aronsson-Storrier and Oliver Fairhurst from Lewis Silkin report on recent litigation in the UK against the developers of AI generation software. This litigation has arisen amongst a flurry of recent interest in AI generated works. In just the past year the IPKat has hosted a number contributions... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/02/never-too-late-if-you-missed-ipkat-last.html We can’t believe it’s already February. Here’s what you missed last week. Patents Benjamin unpacked a patent royalties dispute between the University of Oxford and a student inventor, where the English High Court explained which categories of students should be treated as consumers for the purposes of consumer protection... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/01/daniel-alexander-kc-says-no-on.html The AmeriKat ignoring you after being told“no” A few weeks ago, the IPKat reported on the decision in Oxford University Innovation v Oxford Nanoimaging [2022] EWHC 3200 (IPKat report here). In that case (at a whopping 651 paragraphs), the Court held that students can, in certain situations, be “consumers” vis... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/01/the-geographical-indications-movement.html According to Voltaire, “each player must accept the cards life deals him or her; but once they are in hand, he or she alone must decide how to play the cards in order to win the game.” This quote best encapsulates The legal construction of geographical indications in Africa... Continue reading
In: The IPKat BLOG
http://ipkitten.blogspot.com/2023/01/confidentiality-restrictions-around.html The recent Board of Appeal decision in T 0670/20 considered whether patients in a clinical trial were under conditions of confidentiality. The patent was for a tablet formulation that had been given to patients in a clinical trial conducted before the patent had been filed. The question became whether the patients... Continue reading
Designed by Industrial Action
Copyright © 2026 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION